QTRX

Stats

Summary

quanterix offers an ultra-sensitive diagnostic platform capable of measuring individual proteins at concentrations 1000 times lower than the best immunoassays available today. the single molecule array (simoa™) technology at the heart of the platform enables the detection and quantification of biomarkers previously difficult or impossible to measure, opening up new applications to address significant unmet needs in life science research, in-vitro diagnostics, companion diagnostics, blood screening, and more. quanterix is a venture capital backed company and the exclusive licensee of a broad intellectual property portfolio initially developed at tufts university by dr. david walt, scientific founder of quanterix and illumina (nasdaq: ilmn).

Market Cap: 1.08 Billion

Primary Exchange: NASDAQ

Website: quanterix.com

Shares Outstanding: 38.1 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 1.3000344060791034

Sector: Professional, Scientific, and Technical Services

Industry: Testing Laboratories

Ethical Flags

Longest drawdown: 342 trading days

From: 2018-01-25 To: 2019-02-22

Lowest Point:

Ex-Date	Payment Date	Record Date	Declared Date	Amount	Flag	Dividend Type	Qualified	Indicated

Ex-Date	Declared Date	Record Date	Payment Date	Ratio	To Factor	For Factor